Clinical trials
Phase 1/2 Burkitt Lymphoma trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 3 |
| Completed | 2 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| Autolus Limited | 2 |
| Bristol-Myers Squibb | 1 |
| Celgene | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Millennium Pharmaceuticals, Inc. | 1 |
| Queen Mary University of London | 1 |
| University College, London | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Burkitt Lymphoma | 10 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
| Leukemia | 2 |
| Recurrence | 2 |
| Hodgkin Disease | 1 |
| Lymphoma, Extranodal NK-T-Cell | 1 |
| Lymphoma, Large-Cell, Anaplastic | 1 |
| Lymphoma, Mantle-Cell | 1 |
| Lymphoma, Non-Hodgkin | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.